[Late effects following childhood cancer treatment : A special challenge for transition medicine]
- PMID: 30229367
- DOI: 10.1007/s00108-018-0496-0
[Late effects following childhood cancer treatment : A special challenge for transition medicine]
Abstract
Background: Childhood cancer survivors are at risk of cancer- and treatment-related chronic health conditions. Since these sequelae may occur years after the end of treatment, many patients are already adults and have completed pediatric oncological care. Thus, successful transition is essential in order to ensure long-term surveillance.
Objectives: The present review outlines the most frequent late effects of childhood cancer treatment. Moreover, difficulties in transition of these patients are discussed and interdisciplinary models of care are presented.
Results: Late effects following childhood cancer treatment occur in over two thirds of patients 30 years after the end of the oncological treatment and can affect different organs. The most frequent sequelae are endocrine disturbances, cardiac conditions, and subsequent neoplasms. Many late effects are effectively manageable if detected early. This necessitates an interdisciplinary approach as well as life-long surveillance.
Conclusions: Transition from pediatric to internal medicine care as well as a change in the focus of care, shifting from relapse centered follow-up to late-effects centered surveillance, constitute a special challenge for a successful transition of long-term childhood cancer survivors. Specialized late-effects survivorship clinics offering interdisciplinary care from pediatric oncologists, specialists of internal medicine, and further disciplines enable the early diagnosis and treatment of late-effects.
Keywords: Aftercare, long-term; Delivery of health care; Endocrine system diseases; Interdisciplinary communication; Models of care.
Similar articles
-
Late Effects and Long-Term Follow-Up after Cancer in Childhood.Oncol Res Treat. 2017;40(12):746-750. doi: 10.1159/000484936. Epub 2017 Nov 29. Oncol Res Treat. 2017. PMID: 29183026 Review.
-
Multidisciplinary Late Effects Clinics for Childhood Cancer Survivors in Germany - a Two-Center Study.Oncol Res Treat. 2018;41(7-8):430-436. doi: 10.1159/000488203. Epub 2018 Jun 15. Oncol Res Treat. 2018. PMID: 29902787
-
Healthcare system barriers to long-term follow-up for adult survivors of childhood cancer in British Columbia, Canada: a qualitative study.J Cancer Surviv. 2018 Jun;12(3):277-290. doi: 10.1007/s11764-017-0667-3. Epub 2017 Dec 8. J Cancer Surviv. 2018. PMID: 29222704 Free PMC article.
-
Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work.Oncol Res Treat. 2020;43(3):61-69. doi: 10.1159/000504200. Epub 2020 Jan 13. Oncol Res Treat. 2020. PMID: 31931503 Review.
-
Caring for survivors of childhood cancer: it takes a village.Curr Opin Pediatr. 2018 Dec;30(6):864-873. doi: 10.1097/MOP.0000000000000681. Curr Opin Pediatr. 2018. PMID: 30124580 Review.
Cited by
-
Follow-up care needs and motivational factors for childhood cancer survivors and their parents in Germany.Sci Rep. 2025 Jan 6;15(1):972. doi: 10.1038/s41598-024-84156-y. Sci Rep. 2025. PMID: 39762346 Free PMC article.
-
Organizing long-term follow-up care for pediatric cancer survivors: a socio-ecological approach.Front Public Health. 2025 Mar 3;13:1524310. doi: 10.3389/fpubh.2025.1524310. eCollection 2025. Front Public Health. 2025. PMID: 40098799 Free PMC article.
-
VersKiK qualitative study design: actual follow-up needs of paediatric cancer survivors, their informal caregivers and follow-up stakeholder perceptions in Germany.BMJ Open. 2024 Feb 7;14(2):e072860. doi: 10.1136/bmjopen-2023-072860. BMJ Open. 2024. PMID: 38326270 Free PMC article.
-
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer: A Nationally Representative Study.Am J Clin Oncol. 2024 Oct 1;47(10):485-495. doi: 10.1097/COC.0000000000001123. Epub 2024 Jun 24. Am J Clin Oncol. 2024. PMID: 38913415
-
An ex vivo organ culture screening model revealed that low temperature conditions prevent side effects of anticancer drugs.Sci Rep. 2022 Feb 23;12(1):3093. doi: 10.1038/s41598-022-06945-7. Sci Rep. 2022. PMID: 35197531 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical